Concentrations of erythromycin in maturing Chinook salmon after intraperitoneal injection of one of two drug formulations

Journal of Aquatic Animal Health

Volumn 11, Issue 1, 1999, Pages 61-67

  Haukenes, Alf H ^a,b   Moffitt, Christine M ^a  

^a UNIVERSITY OF IDAHO   (United States)

^b University of South Dakota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; ERYTHROMYCIN PHOSPHATE;

ONCORHYNCHUS TSHAWYTSCHA;

EID: 0033036777     PISSN: 08997659     EISSN: 15488667     Source Type: Journal    
DOI: 10.1577/1548-8667(1999)011<0061:COEIMC>2.0.CO;2     Document Type: Article

References (36)

1. Amacher, D. E., S. J. Schomaker, and J. A. Retsema. 1991. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrobial Agents and Chemotherapy 35:1186–1190.
2. Armstrong, R. D., T. P. T. Evelyn, S. W. Martin, W. Dorward, and H. W. Ferguson. 1989. Erythromycin levels within eggs and alevins derived from spawning broodstock chinook salmon Oncorhynchus tshawytscha injected with the drug. Diseases of Aquatic Organisms 6:33–36.
3. Austin, B. 1985. Evaluation of antibacterial compounds for the control of bacterial kidney disease in rainbow trout, Salmo gairdneri. Journal of Fish Diseases 8:209–220.
4. Bandin, I., Y. Santos, A. E. Toranzo, and J. L. Baria. 1991. MIC’s and MBC’s of chemotherapeutic agents against Renibacterium salmoninarum. Antimicrobial Agents and Chemotherapy 35:1011–1013.
5. Brown, L. L., L. J. Albright, and T. P. T. Evelyn. 1990. Control of vertical transmission of Renibacterium salmoninarum by antibiotics into maturing female coho salmon Oncorhynchus kisutch. Diseases of Aquatic Organisms 9:127–131.
6. Bullock, G. L., and S. L. Leek. 1986. Use of erythromycin in reducing vertical transmission of bacterial kidney disease. Veterinary and Human Toxicology 28(Supplement 1):18–20.
7. Cachet, T., P. Lannoo, J. Paesen, G. Janssen, and J. Hoogmartens. 1992. Determination of erythromycin by liquid chromatography. Journal of Chromatography 600:99–108.
8. Clark, W. G., D. C. Brater, and A. R. Johnson. 1992. Goth’s medical pharmacology. Mosby-Year Book, Saint Louis, Missouri.
9. Elliott, D. G., R. J. Pascho, and G. L. Bullock. 1989. Developments in the control of bacterial kidney disease of salmonid fishes. Diseases of Aquatic Organisms 6:201–215.
10. Evelyn, T. P. T., J. E. Ketcheson, and L. Prosperi-Porta. 1986. Use of erythromycin as a means of preventing vertical transmission of Renibacterium salmoninarum. Diseases of Aquatic Organisms 2:7–11.
11. Evenden, A. J., T. H. Grayson, M. L. Gilpin, and C. B. Munn. 1993. Renibacterium salmoninarum and bacterial kidney disease-the unfinished jigsaw. Annual Review of Fish Diseases 3:87–104.
12. Flood, L. P., and five coauthors. 1996. Reduction in hepatic microsomal P-450 and related catalytic activity in farm-raised red drum. Journal of Aquatic Animal Health 8:13–21.
13. Goksøyr, A., and H. E. Larsen. 1991. The cytochrome P450 system of Atlantic salmon (Salmo salar): I. Basal properties and induction of P450 1A1 in liver of immature and mature fish. Fish Physiology and Biochemistry 9:339–349.
14. Greenlees, K. J. 1997. Laboratory studies for the approval of aquaculture drugs. Progressive Fish-Culturist 59:141–148.
15. Groman, D. B., and G. W. Klontz. 1983. Chemotherapy and prophylaxis of bacterial kidney disease with erythromycin. Journal of the World Mariculture Society 14:226–235.
16. Janecek, M., M. A. Quilliam, M. R. Bailey, and D. H. North. 1993. Determination of erythromycin A by liquid chromatography and electrochemical detection with application to salmon tissue. Journal of Chromatography 619:63–69.
17. Kato, Y., T. Yokozama, M. Shimokawa, and J. Kabe. 1993. Determination of erythromycin in human plasma and whole blood by high-performance liquid chromatography. Journal of Liquid Chromatography 16:661–680.
18. Larrey, D., and six coauthors. 1983. Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochemical Pharmacology 32:1063–1068.
19. Larsen, H. E., M. Celander, and A. Goksøyr. 1992. The cytochrome P450 system of Atlantic salmon (Salmo salar): II. Variations in hepatic catalytic activities and isozyme patterns during an annual reproductive cycle. Fish Physiology and Biochemistry 10:291–301.
20. Lee, E. G. H., and T. P. T. Evelyn. 1994. Prevention of vertical transmission of the bacterial kidney disease agent Renibacterium salmoninarum by broodstock injection with erythromycin. Diseases of Aquatic Organisms 18:1–4.
21. Mehta, C. R., and N. R. Patel. 1992. StatXact: statistical software for exact nonparametric inference. Cytel Software Corp., Cambridge, Massachusetts.
22. Mehta, C. R., N. R. Patel, and R. Gray. 1985. On computing an exact confidence interval for the common odds ratio in several 2 3 2 contingency tables. Journal of the American Statistical Association 80(392): 969–973.
23. Moffitt, C. M. 1991. Oral and injectable applications of erythromycin in salmonid fish culture. Veterinary and Human Toxicology 33:49–53.
24. Moffitt, C. M., and A. H. Haukenes. 1995. Regional investigational new animal drug permits for erythromycin as a feed additive and injectable drug. Progressive Fish-Culturist 57:97–101.
25. Moffitt, C. M., and J. A. Schreck. 1988. Accumulation and depletion of orally administered erythromycin thiocyanate in tissues of chinook salmon. Transactions of the American Fisheries Society 117:394–400.
26. Moffitt, C. M., and Y. Kiryu. 1999. Toxicity, teratogenesis, and efficacy of injectable erythromycin (Erythro-200) administered repeatedly to adult spring chinook salmon. Journal of Aquatic Animal Health 11:1–9.
27. Paesen, J., E. Roets, and J. Hoogmartens. 1991. Liquid chromatography of erythromycin and related substances on poly(styrene-divinylbenzene). Chromatographia 32:162–166.
28. Periti, P., T. Mazzei, E. Mini, and A. Novo. 1989. Clinical pharmacokinetic properties of macrolide antibiotics: effects of age and various pathophysiological states. Clinical Pharmocokinetics 16:193–214.
29. Pleasance, S., and eight coauthors. 1992. Determination of erythromycin A in salmon tissue by liquid chromatography with ion-spray mass spectrometry. Biological Mass Spectrometry 21:675–687.
30. Pratt, W. B., and P. Tayler. 1990. Principles of drug action: the basis of pharmacology, 3rd edition. Churchill Livingstone, New York.
31. SAS Institute. 1989. SAS/STAT user’s guide, version 6, 4th edition. SAS Institute, Cary, North Carolina.
32. Stoffregen, D. A., P. R. Bowser, and J. G. Babish. 1996. Antibacterial chemotherapeutants for finfish aquaculture: a synopsis of laboratory and field efficacy and safety studies. Journal of Aquatic Animal Health 8:181–207.
33. USFDA (U.S. Food and Drug Administration), Center for Veterinary Medicine. 1995. Aquaculture drug use: answers to commonly asked questions. USFDA, Center for Veterinary Medicine, Rockville, Maryland.
34. Williams, D. E., B. S. Masters, J. J. Lech, and D. R. Buhler. 1986. Sex differences in cytochrome P-450 isozyme composition and activity in kidney microsomes of mature rainbow trout. Biochemical Pharmacology 35:2017–2023.
35. Wolf, K., and C. E. Dunbar. 1959. Test of 34 therapeutic agents for control of bacterial kidney disease in trout. Transactions of the American Fisheries Society 88:117–124.
36. Wrighton, S. A., and five coauthors. 1985. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. Biochemistry 24:2171–2178.